FILTER BY:
Intravitreal anti–vascular endothelial growth factor (VEGF) therapy has re…
Expiration Date: 2/16/2023
Max Credits: 0
View Activity
Although clinical trials of anti-vascular endothelial growth factor therap…
Expiration Date: 12/15/2022
The incorporation of intravitreal therapy into treatment protocols for neo…
Expiration Date: 10/27/2021
Evolving advances for the treatment of neovascular retinal diseases have t…
Expiration Date: 10/29/2021
Visual outcomes in patients with neovascular age-related macular degenerat…
Expiration Date: 10/20/2021
The continued refinement of treatment protocols for the management of reti…
Expiration Date: 10/1/2021
Intravitreal therapy has rapidly evolved to become a mainstay of treatment…
Expiration Date: 4/23/2021
Age-related macular degeneration (AMD), a leading cause of blindness in th…
Expiration Date: 4/12/2021
Protocols for the management and treatment of retinal diseases continue to…
The current goal for the management of patients with neovascular age-relat…